Marker therapeutics, inc. (MRKR)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Cash Flows from Operating Activities:
Net loss

-21,427

-147,957

-

-

-

-

-

-

-

Net loss

-

-

-10,982

-2,455

-34,066

-30,883

-5,532

-

-2,028

Net loss

-

-

-

-

-

-

-

-6,171

-

Reconciliation of net loss to net cash used in operating activities:
Depreciation and amortization

105

-

-

-

-

-

-

-

-

Changes in fair value of warrant liabilities

-18

40

-5

-5,939

27,872

-0

-

-

-

Shares issued in debt settlement agreements

-

-

-

70

24

-

-

-

-

Accounts payable settled in common stock

-

-

-

-

-

-

558

-

-

Accrued interest

-

-

-

-

-

-

0

-

-

Depreciation

-

-

-

-

-

-

-

0

-

Depreciation

-

-

-

-

-

-

-

-

0

Shares issued in debt settlement agreements

-

-

-

-

-

-

-

-104

0

Non-cash interest and financing charges

-

-

-

-

-

-

-

-

679

Stock-based compensation

5,356

16,350

2,738

1,558

1,705

1,391

132

2,440

1,261

Amortization on right-of-use assets

181

-

-

-

-

-

-

-

-

Changes in fair value of derivative liabilities

-

-

-

-

-

-

-1,546

-

-

Loss on extinguishment of debt

-

-

-

-

-

26,884

2,560

-

-

Accretion of discount on convertible notes

-

-

-

-

-

492

1,110

-

-

Non-cash interest and finance charges

-

-

-

-

10

83

-

-

-

Changes in fair value of derivative liabilities

-

-

-

-

-

-

-

229

668

Loss on settlement of debt

-

-

-

-

-

-

-

59

-

Loss (gain) on settlement of debt

-

-

-

-

-

-

-

-

317

Gain on extinguishment of derivative liabilities- warrants

-

-

-

-

-

-

-

0

290

Loss on disposal of assets

-

-

-

-

-

-

-

0

0

Non-cash interest and finance charges

-

-

-

-

-

-

645

0

-

Debt extinguishment gain

-

-

492

0

-

-

-

-

-

Research and development - intellectual property acquired

-

116,044

0

-

-

-

-

-

-

Foreign exchange loss

-

-

-

-

-

-58

0

-

-

Changes in operating assets and liabilities:
Prepaid expenses and deposits

1,384

90

-18

1

-13

67

-

-

-

Interest receivable

-51

108

-

-

-

-

-

-

-

Due from government agency

-

-

-

-

-

-

-

-0

0

Prepaid expenses and deposits

-

-

-

-

-

-

0

-41

-

Prepaid expenses and deposits

-

-

-

-

-

-

-

-

-55

Deferred financing costs

-

-

-

-

-

-

24

5

-58

Accounts payable and accrued expenses

-963

1,241

283

257

96

-145

1,835

2,015

-66

Lease liability

-185

-

-

-

-

-

-

-

-

Lease liability

-185

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-4,343

-

-

-

-

Private placements

-

-

-

-

2,464

-

-

-

-

Finders fee and legal costs on private placements

-

-

-

-

137

-

-

-

-

Research agreement obligations

-

-

-

-

-

-

76

156

117

Net cash used in operating activities

-18,284

-14,479

-8,439

-6,509

-

-2,187

-694

-1,588

-

Cash Flows from Investing Activities:
Purchase of property and equipment

374

147

0

-

-

-

-

0

0

Cash acquired on reverse acquisition

-

-

-

-

-

-

-

0

0

Net cash used in investing activities

-374

-147

0

-

-

-

-

-

0

Cash Flows from Financing Activities:
Proceeds from issuance of common stock and warrants in private placement, net of offering costs

-

66,945

5,408

2,331

-

-

-

-

-

Proceeds from exercise of stock options

57

18

0

18

0

-

-

-

-

Proceeds from exercise of warrants

758

4,353

619

5,483

9,219

-

-

-

-

NET CASH USED IN OPERATING ACTIVITIES

-

-

-

-

-

-

-

-

-1,309

Issuance of shares, net of finders' fee

-

-

-

-

-

1,877

0

555

683

Repayment of promissory note

-

-

-

-25

0

-

-

-

-

Convertible notes issuance

-

-

-

-

-

-

728

-

-

Proceeds from loans payable

-

-

-

-

-

-

32

3

0

Repayment of promissory note - related party

-

-

-

23

0

-

30

-

-

Repurchase of common stock to pay for employee withholding taxes

-

71

310

0

-

-

-

-

-

Finders' fee on exercise of warrants

-

-

-

-

767

-

-

-

-

Net cash provided by (used in) financing activities

-

-

-

-

10,778

-

-

-

-

Convertible note issuance

-

-

-

-

-

418

738

602

724

Notes and loans payable

-

-

-

-

-

-

-

0

0

Advances from related parties

-

-

-

-

-

-

-

212

-

Repayment of convertible notes

-

-

-

-

-

-

20

-

-

Repayment of promissory notes

-

-

-

-

-

-15

0

-

-

Repayment of convertible notes

-

-

-

-

-

-

-

0

-

Advances from related parties

-

-

-

-

-

-

-

-

-11

Stock subscriptions

-

-

-

-

-

-

-

0

140

Net cash provided by financing activities

816

71,245

5,717

7,784

-

2,280

709

1,372

1,536

Net decrease in cash

-17,842

56,617

-

-

-

-

-

-

-

NET CASH PROVIDED FROM INVESTING ACTIVITIES

-

-

-

-

-

-

-

0

-

Net decrease in cash

-

-

-2,721

1,274

6,434

93

14

-216

-

INCREASE (DECREASE) IN CASH

-

-

-

-

-

-

-

-

226

Supplemental schedule of non-cash financing activities:
Fair value of repriced warrants as inducement

-

727

-

-

-

-

-

-

-

Stock warrants cashless exercised

0

0

-

-

-

-

-

-

-

Fair value of repriced warrants as inducement

-

727

622

0

-

-

-

-

-

Stock warrants cashless exercised

-

-

0

-

-

-

-

-

-

Fair value of repriced warrants as inducement

-

727

622

0

-

-

-

-

-

Cash paid for interest

-

-

-

-

0

-

-

-

-

Cash paid for taxes

-

-

-

-

0

-

-

-

-

Reclassification of accrued liability upon issuance of common shares relating to Dr. Glynn Wilsons compensation

-

-

-

191

0

-

-

-

-

Accounts payable settled in common stock

-

-

-

-

22

-

-

-

-

Fair value of issuance of series F and F-1 warrants as inducement in August 2016

-

-

-

5,352

0

-

-

-

-

Fair value of shares issued as inducement on August 10, 2016

-

-

-

4,500

0

-

-

-

-

Reclassification of fair value of derivative liabilities to equity on amendment of warrant agreements

-

-

-

15,465

0

-

-

-

-

Fair value of issuance of warrants in January and March 2015 financing

-

-

-

-

9,313

-

-

-

-

Issuance of additional warrants in May 28, 2015 transaction

-

-

-

-

6,133

-

-

-

-

Reclassification of Derivative Warrant Liabilities to Equity at exercise date

-

-

-

5,074

16,835

-

-

-

-

Accounts payable settled in common stock

-

-

-

-

-

2,415

-

-

-

Accrued interest

-

-

-

-

-

525

-

-

-

Convertible notes payable

-

-

-

-

-

4,116

-

-

-

Loans payable, related party

-

-

-

-

-

42

-

-

-

Promissory notes, related party

-

-

-

-

-

210

0

-

-

Due to related parties

-

-

-

-

-

369

-

-

-

Fair value derivative liability - conversion opt at conversion

-

-

-

-

-

708

-

-

-

Due to related parties

-

-

-

-

-

-

0

-

-

Fair value derivative liability - conversion option at conversion

-

-

-

-

-

-

0

-

-

CASH, BEGINNING OF YEAR

-

-

-

-

-

-

-

250

-

CASH, END OF YEAR

-

-

-

-

-

-

-

33

-